Stem Point Capital LP Syndax Pharmaceuticals Inc Transaction History
Stem Point Capital LP
- $378 Billion
- Q1 2024
A detailed history of Stem Point Capital LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Stem Point Capital LP holds 1,100,988 shares of SNDX stock, worth $21.2 Million. This represents 6.93% of its overall portfolio holdings.
Number of Shares
1,100,988
Previous 1,094,494
0.59%
Holding current value
$21.2 Million
Previous $23.7 Billion
10.79%
% of portfolio
6.93%
Previous 6.31%
Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
195Shares Held
90MCall Options Held
353KPut Options Held
207K-
Black Rock Inc. New York, NY7.55MShares$146 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.44MShares$143 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.66MShares$109 Million14.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$94.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.82MShares$92.9 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.09B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...